GelSana Selected for MedTech Innovator 2025 Cohort

GelSana Therapeutics, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies. GelSana is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program. This recognition reflects the incredible work of our team and validates the potential of our solution to make a meaningful impact on healthcare.